NMRD OTC
Nemaura Medical Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$77K
-84.7% ▼
Gross Profit
-$1M
-1025.0% ▼
Operating Income
-$10M
-26.7% ▼
Net Income
-$14M
-1.9% ▼
EPS (Diluted)
$-0.57
+3.4% ▲
EBITDA
-$7M
+0.7% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $504K | $77K |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | -84.7% |
| Cost of Revenue | $0 | $0 | $98K | $344K | $2M |
| Gross Profit | $0 | $0 | -$98K | $160K | -$1M |
| Gross Margin | — | — | — | 31.7% | -1916.3% |
| R&D Expenses | $2M | $2M | $2M | $2M | $2M |
| SG&A Expenses | $2M | $3M | $3M | $6M | $6M |
| Operating Expenses | $4M | $5M | $5M | $8M | $8M |
| Operating Income | -$4M | -$5M | -$5M | -$8M | -$10M |
| Operating Margin | — | — | — | -1502.3% | -12454.2% |
| Interest Expense | $0 | $0 | $2M | $7M | $6M |
| Income Before Tax | -$4M | -$5M | -$7M | -$14M | -$14M |
| Tax Expense | $24K | -$614K | -$336K | -$350K | $0 |
| Net Income | -$4M | -$4M | -$6M | -$14M | -$14M |
| Net Margin | — | — | — | -2755.8% | -18358.0% |
| EPS (Diluted) | $-0.25 | $-0.20 | $-0.28 | $-0.59 | $-0.57 |
| EBITDA | -$4M | -$5M | -$4M | -$7M | -$7M |
| Shares Outstanding | 18M | 21M | 22M | 23M | 25M |